COPD activates bitter taste receptors, the target of asthma treatment

Published Date: 17 Mar 2023

Germany: Activation of bitter taste receptors opens lung pathways, making them potential targets for the treatment of chronic lung diseases...

Read Full News

Latest News

Australia Confirms First H5N1 Bird Flu Case in Local Mammal

Australia on Sunday confirmed its first case of H5N1 bird flu in a mammal, with the deadly virus ⁠found in a long-nosed fur seal in South Australia state.

Nerandomilast Lowers Mortality Risk in Pulmonary Fibrosis

Nerandomilast is associated with reduced mortality risk in patients with pulmonary fibrosis, a pooled analysis of two trials shows.

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Expert Insights on the Next Wave of IO Combinations in mNSCLC

Expert Insights on the Next Wave of IO Combinations in mNSCLC

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

New GLP-1 Concern; FDA Sued by Health Groups; Over 750 Dead in Ebola Outbreak

Health news and commentary gathered by MedPage Today staff

Todays Updates

Thymus Radiation Exposure Tied to Worse Lung Cancer Outcomes

The thymus is not routinely considered during thoracic radiotherapy planning, but new findings suggest that may need to change.

FDA Approves Rusfertide for Polycythemia Vera

Adding rusfertide to standard-of-care treatment cut phlebotomy rates by more than half in the phase 3 VERIFY trial.

Todays Updates

Thymus Radiation Exposure Tied to Worse Lung Cancer Outcomes

The thymus is not routinely considered during thoracic radiotherapy planning, but new findings suggest that may need to change.

FDA Approves Rusfertide for Polycythemia Vera

Adding rusfertide to standard-of-care treatment cut phlebotomy rates by more than half in the phase 3 VERIFY trial.

Latest News

Australia on Sunday confirmed its first case of H5N1 bird flu in a mammal, with the deadly virus ⁠found in a long-nosed fur seal in South Australia state.

Nerandomilast is associated with reduced mortality risk in patients with pulmonary fibrosis, a pooled analysis of two trials shows.

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Expert Insights on the Next Wave of IO Combinations in mNSCLC

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

Health news and commentary gathered by MedPage Today staff

News All Time

Real-World Study Backs Mepolizumab in Rhinosinusitis With Nasal Polyps

— 20% of patients were on their way to remission

Tenax Heart Drug Fails to Improve Walking Results in Study, Shares Plunge

Tenax Therapeutics said on Monday its experimental drug did not significantly improve how far patients could walk compared with ⁠placebo in a late-stage trial for a...

Overheard in Medicine: Pandemic Wounds Reopened

Overhead in Medicine is a Medscape digest that surfaces a few of the week’s top posts from major medical subreddits.

Ivacaftor Boosts Height and Lung Function in Cystic Fibrosis

Children and young adults with cystic fibrosis, especially those with severe CFTR variants, who receive ivacaftor have improved height and lung capacity than peers who do not receive ivacaftor.

Housing Aid Linked to Better NSCLC Survival

Housing assistance was associated with lower mortality among older adults with NSCLC, but the survival advantage was not explained by differences in guideline-concordant treatment.

More Bronchiectasis Patients Benefit From HEMT

Data from the US Bronchiectasis and NTM Research Registry show improvements in cough and exacerbations with highly effective modulator therapy.

Integrating Evolving IO Strategies in Frontline mNSCLC Management

Integrating Evolving IO Strategies in Frontline mNSCLC Management

Case Report: Paradoxical Bronchoconstriction with Short-Acting Beta Agonist

Clinicians perform pulmonary function tests to find the cause

Why Is a Fit Swimmer Breathless and Coughing Up Blood?

Case highlights a little-known, potentially dangerous, often recurrent condition of swimmers

Psychosis and Cannabis Legalization: Where's the Evidence?

As marijuana policy shifts nationwide, researchers are tracking possible link to psychosis

FDA Staff Blindsided by Move Allowing More E-Cigs, Nicotine Pouches Onto Market

It's highly unusual for the FDA to draft new policies without input from the staffers

Chronic Sinus Inflammation Linked to Roadway Gases

Gaseous pollutants from traffic sources add to evidence for particulate-matter harms

Targeted Lung Cancer Drug Aces Confirmatory Trial in Frontline Setting

Upfront treatment options set to expand for NSCLC patients with EGFR exon 20 insertions

Drug Combo for Lung Cancer Beats Pembrolizumab in First-Line Trial

Antibody-drug conjugate plus pembrolizumab superior to pembrolizumab alone in PD-L1 expressors

Upfront Ivonescimab Plus Chemo Bests PD-1 Inhibitor Combo in Advanced NSCLC

HARMONi-6 showed 34% drop in death risk, but trial had an all-Asian population, expert warned

'Immediately Practice-Changing' Lung Cancer Trial in Curative Setting

Substantial EFS improvement with selpercatinib in RET fusion-positive disease

Recommended News For You

X-ray and radar technology combined to reduce cancer screening risks

Exercise may help breast cancer survivors manage weight

Unified Neuro/Psych Residency Program: New Proposal.

Study suggests exercise could reduce breast cancer recurrence

Vapers May Be Less Likely to Undergo Lung Cancer Screening

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

The acceptance of innovative hormonal therapy for advanced prostate cancer is racialized.

Recommended Articles For You

Demystifying Hematoma Rectus Sheath: Knowing the Symptoms and Causes 

Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment  

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization 

Case-Based Learning on Adaptive Management of Oligometastatic Disease Across Treatment Phases 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Can Concurrent Boost Safely Shorten Breast Cancer Radiation?

2.

Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer

3.

Ultrasound bras; HPV and thyroid cancer; language minimizing adverse events.

4.

In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.

5.

The FDA Approves the New Frontline Aggressive ALL Regimen.

1.

Hematopoietic Stem Cell Exhaustion in Blood Disorders

2.

Lymphomatoid Papulosis: What You Need to Know

3.

The Growing Crisis of Aplastic Anemia: A Call for Action

4.

Importance of Early Detection in Hematology

5.

Clonal Hematopoiesis Dynamics and Future Hematologic Outcomes

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part X

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV

4.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective

5.

Lung Cancer: Risk Factors and Prevention

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot